2 Main Types of Uterine Cancer: Which Is More Common?
:max_bytes(150000):strip_icc()/Health-GettyImages-2106987488-1850c43a93244609a8726351942a6806.jpg?w=780&resize=780,470&ssl=1)
:max_bytes(150000):strip_icc():format(jpeg)/Health-GettyImages-2106987488-1850c43a93244609a8726351942a6806.jpg)
Uterine cancer develops in the tissues of the uterus, the hollow organ of the basin where a fetus could develop and develop during pregnancy. There are two main types of uterine cancer. The most common type is endometrial cancer. The other type is a uterine sarcoma.
The two main types of uterine cancer are endometrial cancer and uterine sarcoma. The two have different subtypes depending on what cancer cells look like. Knowing the types of uterine cancer and their symptoms can help you recognize the signs of early alert and seek appropriate treatment.
1. Endometrium cancer
The endometrial cancer refers to cancer which begins in the inner mucosa of the uterus, known as endometrium. It is the most common type of uterine cancer in the United States. Health care providers can classify endometrial cancer in the following subtypes:
- Endometrial adenocarcinoma:: Most cases of endometrial cancer (approximately 75%) are adenocarcinomas of the endometrium. Health care providers can further subdivide adenocarcinomas in other types, the most common being endometrium cancer. This type of cancer begins in the glandular cells (cells that secrete substances) of the endometrium.
- Uterine carcinosarcoma:: This subtype begins in the endometrium. It represents approximately 3% of all cases of uterus cancer and can be more aggressive than other types of endometrial cancer.
Other types of endometrial cancer are very rare. They understand Entometrial epidermoid carcinoma (represents less than 1% of all uterine cancers) and Small endometrial cell carcinoma (Extremely rare, is easily spread and is difficult to treat).
2. Uterine sarcomas
Sarcomas are cancer tumors that develop in muscle, fat, bone or fibrous tissues. Uterine sarcomas, in particular, are a type of uterine cancer that begins in the muscle layer or the connective tissue of the uterus.
This cancer tends to be more aggressive than endometrial cancer. Uterine sarcomas are rarer, representing approximately 2 to 5% of all cases of uterine cancer in the United States
These cancers can be classified according to the type of cell affected by cancer. The subtypes include:
- Uterine leiomyosarcoma (LMS): This subtype is developing in the myometer, which is the muscular layer of the uterus. This is the most common type of uterine sarcoma. It tends to spread quickly.
- Stromal endometrial sarcoma (ESS): This subtype begins in the Stroma, which is the connective tissue in the mucosa of the uterus. Health care providers are testing to determine the NSS cancer note. High grade tumors tend to be more aggressive and to spread easily, like many uterine sarcomas. Low grade tumors can be more treatable and have better perspectives.
- Indifferent sarcoma: This subtype can start in the uterine lining (endometrium) or the muscle layer (myometer). Cancer is aggressive and generally spreads quickly.
- Adenosarcoma: This subtype begins in the connective tissue (stroma) of the uterus. Tumors tend to spread slowly and generally have a good prognosis.
- Perivascular epithelioid cell tumor (Pecoma): This extremely rare subtype generally occurs in the body of the uterus.
Uterine cancers differ depending on their location in the uterus and what cells look like a microscope. A gynecologist (doctor specializing in the reproductive health of women) or a gynecological oncologist (doctor specializing in the diagnosis and processing of women’s cancers) can carry out tests to help determine the type.
Diagnostic tests for uterine cancer may include:
- History and physics: Your supplier will probably carry out an in -depth physical examination and a pelvic exam. They will also ask several questions about your symptoms and your family health history.
- Ultrasound: An ultrasound can provide images of the interior of your uterus, ovaries and fallopian tubes to search for tumors and other signs of cancer. Ultrasound can be an abdominal ultrasound or a transvaginal ultrasound.
- Blood test: Your supplier can use full blood count to check your level of red blood cells. Uterine cancer often causes bleeding and anemia, which are associated with a small number of red blood cells.
- Biopsy: Your supplier can take a fabric sample from your endometrium and send it to a laboratory to search for cancer cells. This can be done in an office or in the operating room.
- Other imaging studies: If you are diagnosed with uterine cancer, your supplier can recommend additional tests such as radiography, computed tomography (CT) or magnetic resonance imaging (MRI) to determine whether cancer cells have spread to other areas of your body.
Consult your health care provider as soon as you develop signs or symptoms of uterine cancer. It is important to discuss these symptoms with your supplier:
- Unusual vaginal bleeding or vaginal spots (the most common symptom)
- New vaginal release
- Pelvic pain
- A mass in the lower belly
- A feeling of fullness in your abdomen or your pelvic area
- Involuntary weight loss
- Frequent urination
- Constipation
Early diagnosis means that you can start the treatment of uterine cancer. These treatments may include:
- Surgery to eliminate cancer
- Chemotherapy
- Radiotherapy
- Targeted therapy
Prevent uterine cancer
There is no proven way to prevent uterine cancer. However, it may be possible to reduce your risk. Try to focus on these strategies:
- Maintain a weight that you and your decided health care provider is optimal for you.
- Engage in regular physical activity.
- Consult your gynecologist or health care provider regularly.
- Speak with your health care provider benefits and risks of hormone therapy if you are in menopause.
- Discuss the regular cancer screening with your supplier if you have been diagnosed with hereditary -free colon cancer (HNPCC), also called LYND syndrome.
There are two main types of uterine cancer. The endometrial cancer, which begins in the mucous membrane of the uterus, is more common. The uterine sarcoma, which begins in the uterine muscle or connective tissue, is rare: about 2 to 5% of people with uterine cancer have uterine sarcoma. Each of these main types can be divided into additional subtypes.




